Perozin ApS
Private limited companyCVR 29183910HaslevActive
Perozin ApS is a private limited company, based in Haslev, active in manufacture of pharmaceutical preparations, founded in 2005. Net profit rose 39% from 2024 to 2025, ending at DKK 1m.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 52% (2024 → 2025), to DKK 2.8m.
- Net profit rose 39% (2024 → 2025), to DKK 1m.
- Equity rose 12% (2024 → 2025), to DKK 9.6m.
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2019–2025 · amounts in DKK thousandEquity and net profit
| 2019 | 2020 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 2,082 | 950 | 2,021 | 1,634 | 1,847 | 2,800 | +51.6% |
| Operating profit (EBIT) | 1,133 | 52 | 1,324 | 1,208 | 1,235 | 1,688 | +36.7% |
| Profit before tax | 1,115 | 20 | 1,282 | 1,162 | 1,126 | 1,369 | +21.7% |
| Net profit | 868 | 14 | 1,000 | 904 | 736 | 1,026 | +39.4% |
| Total assets | 6,281 | 5,861 | 7,485 | 8,506 | 13,166 | 14,440 | +9.7% |
| Equity | 5,475 | 5,607 | 6,978 | 7,882 | 8,618 | 9,644 | +11.9% |
| Liabilities | 796 | 240 | 507 | 624 | 4,365 | 4,560 | +4.5% |
| Cash and cash equivalents | 3,740 | 3,914 | 4,501 | 5,565 | 1,235 | 2,368 | +91.8% |
| Average number of employees | 2 | 3 | 2 | 1 | 1 | 1 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2019, 2020, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures. The register has no financial statements for 2021 (changed financial year or not filed).
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresProfit for five years in a row
Net result has been positive in 2020–2025.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/05/2024 – 30/04/2025 | 19/11/2025 | The company | PDF not statedXBRL |
| 2024 | 01/05/2023 – 30/04/2024 | 31/10/2024 | The company | PDFXBRL |
| 2023 | 01/05/2022 – 30/04/2023 | 16/10/2023 | The company | PDFXBRL |
| 2022 | 01/05/2021 – 30/04/2022 | 27/09/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 17/10/2021 | The company | PDFXBRL |
| 2019 | 01/05/2018 – 30/04/2019 | 27/08/2020 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
59 companies in the databaseComparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.
Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 24,066of 69,742 Better than 65% | No. 9,297of 69,964 Better than 87% |
| Same industry and fewer than 20 employees37 companies in the comparison | No. 12of 36 Better than 69% | No. 10of 37 Better than 75% |
| Companies that are between 15 and 29 years old24,910 companies in the comparison | No. 13,476of 24,791 Better than 46% | No. 6,853of 24,909 Better than 72% |
| All companies of type ApS66,508 companies in the comparison | No. 23,658of 66,379 Better than 64% | No. 7,078of 66,505 Better than 89% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of pharmaceutical preparations- Perozin ApSDKK 2.8m
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Perozin ApSDKK 1m
- Novo Nordisk A/SDKK 102.4bn
- H. Lundbeck A/SDKK 3.2bn
- Perozin ApSDKK 9.6m
- Novo Nordisk A/SDKK 194bn
- H. Lundbeck A/SDKK 24.9bn
- Perozin ApS3
- Novo Nordisk A/S27,279
- H. Lundbeck A/S2,261
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- GEBAL Holding ApS66.67%
- Barghoth Ala Hasan Ali15%
- Ehsan Ahmed Mousa Abdalla Elfarra15%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Gerard Gerner Hansen | Director | 01/11/2005 |
- Founders
- Gerard Gerner Hansen
Signing rule: Selskabet tegnes af direktøren.
Address and production units
1 active production unitsDanmarksgade 4
4690 Haslev
| Production unit | Address | Employees | P number |
|---|---|---|---|
| PEROZIN ApS | Danmarksgade 4, 4690 Haslev | 3 | 1011847265 |
Purpose
Selskabets formål er at drive virksomhed med eksport af eget udviklet gigtmiddel.
The purpose is quoted from the register in Danish.
Changes year by year
22 registered events20251 changeaccounts 1
- AccountsAnnual report for 2025 published
20242 changesaccounts 1 · address 1
- AccountsAnnual report for 2024 published
- AddressMoved to Danmarksgade 4, 4690 Haslev
20231 changeaccounts 1
- AccountsAnnual report for 2023 published
20221 changeaccounts 1
- AccountsAnnual report for 2022 published
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
20201 changeaccounts 1
- AccountsAnnual report for 2019 published
20183 changescapital 1 · ownership 2
- CapitalShare capital changed from 125,000 DKK to 178,572 DKK
- OwnershipBarghoth Ala Hasan Ali registered as owner (15%)
- OwnershipEhsan Ahmed Mousa Abdalla Elfarra registered as owner (15%)
20173 changesownership 2 · address 1
- OwnershipGerard Gerner Hansen is no longer registered as owner
- OwnershipGEBAL Holding ApS registered as owner (66.67%)
- AddressMoved to Navervej 28E, 4000 Roskilde
20083 changesstatus 1 · capital 1 · industry 1
- StatusStatus changed to active
- CapitalShare capital changed from 250,000 DKK to 125,000 DKK
- IndustryIndustry changed to Manufacture of pharmaceutical preparations (212000)
20071 changestatus 1
- StatusStatus changed to under compulsory dissolution
20062 changescapital 1 · industry 1
- CapitalShare capital changed from 125,000 DKK to 250,000 DKK
- IndustryIndustry changed to Aluminium production (244200)
20053 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as PEROZIN ApS
- ManagementGerard Gerner Hansen appointed director
- OwnershipGerard Gerner Hansen registered as owner (100%)
Related companies
Largest in the industry
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Leo Pharma A/SDKK 8.2bn
- Alk-abelló A/SDKK 4.2bn
- Bavarian Nordic A/SDKK 3bn
- Pharmacosmos A/SDKK 1.6bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.